Evidence map›Paper›PMID 37763801›Full record

ArticleMedicina (Kaunas, Lithuania)2023

The Prognostic and Therapeutic Role of Histone Acetylation Modification in LIHC Development and Progression.

Ji Gao, Sheng Han, Jian Gu, Chen Wu, Xiaoxin Mu

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ji GaoHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Sheng HanHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Jian GuHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Chen WuHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Xiaoxin MuHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0003-2573-3879

Funding

National Natural Science Foundation of China 82101873
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsSirtuinsAcetylationHistonesHumansPrognosisTumor MicroenvironmentHistonesSIRT6 protein, humanSirtuinshistone acetylationimmunotherapyLIHCsignaturetumor microenvironment

Identifiers

PMID37763801
PMCPMC10536947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.